SG11202001979PA - Aromatic derivative, preparation method for same, and medical applications thereof - Google Patents

Aromatic derivative, preparation method for same, and medical applications thereof

Info

Publication number
SG11202001979PA
SG11202001979PA SG11202001979PA SG11202001979PA SG11202001979PA SG 11202001979P A SG11202001979P A SG 11202001979PA SG 11202001979P A SG11202001979P A SG 11202001979PA SG 11202001979P A SG11202001979P A SG 11202001979PA SG 11202001979P A SG11202001979P A SG 11202001979PA
Authority
SG
Singapore
Prior art keywords
preparation
same
medical applications
aromatic derivative
derivative
Prior art date
Application number
SG11202001979PA
Other languages
English (en)
Inventor
Ning Shao
Ding Wang
Hongbin Yuan
Frank Kayser
Original Assignee
Bioardis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioardis Llc filed Critical Bioardis Llc
Publication of SG11202001979PA publication Critical patent/SG11202001979PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11202001979PA 2017-09-05 2018-09-04 Aromatic derivative, preparation method for same, and medical applications thereof SG11202001979PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710791233 2017-09-05
PCT/CN2018/104007 WO2019047826A1 (fr) 2017-09-05 2018-09-04 Dérivé aromatique, son procédé de préparation, et ses applications médicales

Publications (1)

Publication Number Publication Date
SG11202001979PA true SG11202001979PA (en) 2020-04-29

Family

ID=65634601

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001979PA SG11202001979PA (en) 2017-09-05 2018-09-04 Aromatic derivative, preparation method for same, and medical applications thereof

Country Status (9)

Country Link
US (1) US11279697B2 (fr)
EP (1) EP3680236A4 (fr)
JP (2) JP7346420B2 (fr)
CN (1) CN110997637B (fr)
CA (1) CA3074885A1 (fr)
PH (1) PH12020500436A1 (fr)
SG (1) SG11202001979PA (fr)
TW (1) TWI817955B (fr)
WO (1) WO2019047826A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020177067A1 (fr) * 2019-03-05 2020-09-10 Bioardis Llc Dérivés aromatiques, procédés de préparation et utilisations médicales de ceux-ci
WO2021060307A1 (fr) * 2019-09-25 2021-04-01 富士フイルム株式会社 Composé imidazopyridine ou sel de celui-ci, et composition pharmaceutique

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
CA2839437A1 (fr) 2011-06-16 2012-12-20 Isis Pharmaceuticals, Inc. Modulation antisens de l'expression du recepteur 4 du facteur de croissance fibroblastique
WO2014011900A2 (fr) 2012-07-11 2014-01-16 Blueprint Medicines Inhibiteurs du récepteur du facteur de croissance de fibroblastes
ES2819398T3 (es) * 2013-07-18 2021-04-15 Taiho Pharmaceutical Co Ltd Agente terapéutico para el cáncer resistente al inhibidor de FGFR
EP3057943B1 (fr) 2013-10-18 2018-04-25 Eisai R&D Management Co., Ltd. Inhibiteurs de fgfr4 pyrimidine
US9434700B2 (en) 2013-10-25 2016-09-06 Neil Bifulco, JR. Inhibitors of the fibroblast growth factor receptor
JP6203954B2 (ja) 2013-10-25 2017-09-27 ノバルティス アーゲー Ｆｇｆｒ４阻害剤としての縮環二環式ピリジル誘導体
US10125090B2 (en) 2014-06-24 2018-11-13 Covestro Deutschland Ag Process for preparation of di- and polyamines of the diphenylmethane series
WO2016064960A1 (fr) * 2014-10-22 2016-04-28 Incyte Corporation Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
EP3029864B1 (fr) 2014-12-01 2020-11-18 Harman Becker Automotive Systems GmbH Affichage rapide d'informations relatives à des émetteurs dans un récepteur fm comportant un seul syntoniseur
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) * 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3259269B9 (fr) 2015-02-20 2020-03-04 Incyte Corporation Heterocycles bicycliques en tant qu'inhibiteurs de fgfr
CN105906630B (zh) 2015-04-06 2018-10-23 四川百利药业有限责任公司 用作fgfr抑制剂的n-(1h-吡唑-5-基)嘧啶并吡唑-4,6-二取代胺类化合物
WO2016164703A1 (fr) 2015-04-09 2016-10-13 Eisai R & D Management Co., Ltd. Inhibiteurs du récepteur fgfr4
CN109224235B (zh) 2018-10-23 2020-05-19 孙喜家 一种双腔管
CN109331654A (zh) 2018-10-26 2019-02-15 高邮高和光电器材有限公司 一种有机废气光催化氧化装置

Also Published As

Publication number Publication date
WO2019047826A1 (fr) 2019-03-14
CN110997637B (zh) 2022-09-27
JP7346420B2 (ja) 2023-09-19
JP2020532581A (ja) 2020-11-12
EP3680236A4 (fr) 2021-04-21
CA3074885A1 (fr) 2019-03-14
TW201912631A (zh) 2019-04-01
TWI817955B (zh) 2023-10-11
PH12020500436A1 (en) 2021-02-08
EP3680236A1 (fr) 2020-07-15
US20200262827A1 (en) 2020-08-20
CN110997637A (zh) 2020-04-10
US11279697B2 (en) 2022-03-22
KR20200083448A (ko) 2020-07-08
JP2023158113A (ja) 2023-10-26

Similar Documents

Publication Publication Date Title
HUE054964T2 (hu) Pirazol-heteroaril készítmény, az elõállítás módja és gyógyászati felhasználása
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
EP3733715A4 (fr) Triacorps, son procédé de préparation et son utilisation
EP3636646A4 (fr) Dérivés d'hétéroaryle pyrazole, leur procédé de préparation et leur application médicale
EP3389757A4 (fr) Tige de cathéter et dispositifs, systèmes et procédés associés
IL256744A (en) A new derivative of pyrizin, its preparation method and medical application
EP3258883A4 (fr) Dispositifs, systèmes et procédés de traitement cardiaque
EP3530656A4 (fr) Dérivé du cycle pyrimidine aromatique à substitution en position 2, préparation et application associées
EP3248963A4 (fr) Dérivé pyrrole sulfonyle, son procédé de préparation et son utilisation médicale
EP3385262A4 (fr) Inhibiteur de protéine kinase, son procédé de préparation et son utilisation médicale
HK1244808A1 (zh) 苯並哌啶類衍生物、其製備方法及其在醫藥上的應用
EP3251698A4 (fr) Conjugé ligand-médicament cytotoxique, procédé de préparation dudit conjugué et application dudit conjugué
EP3330258A4 (fr) Dérivé 1,3,5-triazine et sa méthode d'utilisation
IL272446A (en) Penta-condensed hexa-heterocyclic compounds, method for their preparation, drug combination and use thereof
EP3246327A4 (fr) Dérivé 3-acétylényle-pyrazole-pyrimidine, méthode de préparation et utilisations correspondantes
SG11202007521PA (en) Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof
EP3398958A4 (fr) Polyamino-acide, conjugué protéine-polyamino-acide et procédé de préparation correspondant
EP3395366A4 (fr) Procédé de conception de médicament, médicament obtenu et application associée
EP3572404A4 (fr) Hétérocomplexe de butylphthalide-telmisartan, procédé de préparation et application associés
EP3556769A4 (fr) Dérivé de polyximine, procédé de préparation et application associés
EP3589670A4 (fr) Élastomère, son procédé de préparation et utilisation associée
EP3406602A4 (fr) Composé 1-sulfonamido-4-aryloxy, son procédé de préparation et son application médicinale
EP3556761A4 (fr) Composé hétérocyclique pyrrolo-aromatique, son procédé de préparation et son utilisation médicale
EP3530657A4 (fr) Dérivé pyrimidine à cycle aromatique 2-polysubstitué et préparation et utilisation médicale
EP3450450A4 (fr) Dérivé de la vancomycine, ainsi que procédé de préparation, composition pharmaceutique et utilisation associés